Literature DB >> 99974

Cross-reactions between Neisseria meningitidis and twenty-seven other bacterial species.

G E Hoff, N Høiby.   

Abstract

Cross-reactions between antigens from N. meningitidis and antigens from 27 other bacterial species from clinical isolates representing 20 different genera were studied by quantitative immunoelectrophoretic methods. A water-soluble N. meningitidis antigen preparation and a corresponding pooled rabbit antiserum regularly presenting 48 immunoprecipitates were used as reference system. Antigens from 16 other bacterial genera cross-reacted with one to four N. meningitidis antigens, whereas antigens from six other Neisseria species cross-reacted with 37 to 48 N. meningitidis antigens. Antigens from only three bacterial genera (Streptococcus, Staphylococcus and Bacteroides) did not show any cross-reactions. The degree of cross-reactivity between the antigens were 25--100%, as judged by absorption of antibodies. Three of the cross-reacting antigens reacted with normally occurring precipitating antibodies in serum from humans and rabbits.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 99974     DOI: 10.1111/j.1699-0463.1978.tb00014.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand B        ISSN: 0105-0656


  3 in total

1.  Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis.

Authors:  M K Taha
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Immunogenicity of some common thermolabile surface antigens of Escherichia coli.

Authors:  F Orskov; J C Larsen; I Orskov
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

3.  Cross-reactions between Legionella pneumophila (serogroup 1) and twenty-eight other bacterial species, including other members of the family Legionellaceae.

Authors:  M T Collins; F Espersen; N Høiby; S N Cho; A Friis-Møller; J S Reif
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.